Literature DB >> 3192032

The significance of proteinuria in pre-eclampsia; proteinuria associated with low birth weight only in pre-eclampsia.

T T Lao1, R K Chin, Y M Lam.   

Abstract

To examine the significance of proteinuria in pre-eclampsia, we studied 87 nulliparous patients in whom pre-eclampsia was diagnosed clinically and whose blood pressure and urine findings returned to normal after delivery. There was no difference in the gestation at diagnosis, highest systolic and diastolic blood pressures before treatment/delivery, or the number given antenatal hypotensive therapy between patients with proteinuria (group A, n = 46) and without proteinuria (group B, n = 41). Group A patients had higher plasma urea concentration (p less than 0.02), but similar creatinine and urate concentrations to group B patients. Group A patients had a higher rate of induction of labour (p less than 0.04) and Caesarean section before labour (p less than 0.04), and the mean gestation at delivery as well as the birth weight were less (p less than 0.03 and p less than 0.004, respectively). The results suggest that proteinuria in pre-eclampsia is associated with more severe fetal involvement and growth retardation only, but not with an increased severity of the maternal condition such as hypertension and a higher plasma urate concentration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3192032     DOI: 10.1016/0028-2243(88)90138-4

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

Review 1.  Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review.

Authors:  Anne-Marie Côté; Mark A Brown; Elaine Lam; Peter von Dadelszen; Tabassum Firoz; Robert M Liston; Laura A Magee
Journal:  BMJ       Date:  2008-04-10

Review 2.  Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review.

Authors:  Shakila Thangaratinam; Arri Coomarasamy; Fidelma O'Mahony; Steve Sharp; Javier Zamora; Khalid S Khan; Khaled M K Ismail
Journal:  BMC Med       Date:  2009-03-24       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.